EMPOWERING WOMEN TO OWN THEIR HEALTH

Teva Generics
Oral Contraceptives Guide

Teva Generics offers an extensive line of oral contraceptives. To access accompanying full Prescribing Information, hover over the name of the Teva Generics oral contraceptive that is of interest to you. If you have additional questions about our oral contraceptives, please call 855-OUR-TEVA.

To sort the chart alphabetically by product name, click on the respective heading.

Type of Oral
Contraceptive
Teva Generic
Brand
Strength
Type of Oral Contraceptive Progestin-only
Product Image Yellow compact with Jolivette® blister card
Note
Jolivette® (norethindrone 0.35 mg) Tablets
Note
Brand
Ortho Micronor®
Strength
0.35 mg
Type of Oral Contraceptive Progestin-only
Product Image Yellow compact with Jolivette® blister card
Note
Jolivette® (norethindrone 0.35 mg) Tablets
Strength
0.35 mg
Type of Oral Contraceptive Progestin-only
Product Image Nora-Be® blister card and blue dispenser
Note
Nora-BE® (norethindrone 0.35 mg tablets USP)
Note
Brand
Nor-QD®
Strength
0.35 mg
Type of Oral Contraceptive Progestin-only
Product Image Nora-Be® blister card and blue dispenser
Note
Nora-BE® (norethindrone 0.35 mg tablets USP)
Strength
0.35 mg
Type of Oral Contraceptive Monophasic combination
Product Image Amethyst® blister card and purple dispenser
Note
Amethyst® (levonorgestrel and ethinyl estradiol tablets, USP)
Note: Amethyst® is also listed under “Continuous-cycle combination.”
Note
Note: Amethyst® is also listed under “Continuous-cycle combination.”
Brand
Lybrel®
Strength
90 mcg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Amethyst® blister card and purple dispenser
Note
Amethyst® (levonorgestrel and ethinyl estradiol tablets, USP)
Note
Note: Amethyst® is also listed under “Continuous-cycle combination.”
Strength
90 mcg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Apri® blister card
Note
Apri® (desogestrel and ethinyl estradiol tablets, USP)
Note
Brand
Ortho-Cept®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Apri® blister card
Note
Apri® (desogestrel and ethinyl estradiol tablets, USP)
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Aviane® blister card
Note
Aviane® (levonorgestrel and ethinyl estradiol tablets, USP)
Note
Brand
Alesse®
Strength
0.1 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Aviane® blister card
Note
Aviane® (levonorgestrel and ethinyl estradiol tablets, USP)
Strength
0.1 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Balziva® blister card
Note
Balziva® (norethindrone and ethinyl estradiol tablets, USP)
Note
Brand
Ovcon® 35
Strength
0.4 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Balziva® blister card
Note
Balziva® (norethindrone and ethinyl estradiol tablets, USP)
Strength
0.4 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Turquoise dispenser with 3 Camrese® blister cards
Note
Camrese® (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note: Camrese® is also listed under “Extended-cycle combination.”
Note
Note: Camrese® is also listed under “Extended-cycle combination.”
Brand
Seasonique®
Strength
0.15 mg/0.03 mg; 0.01 mg
Type of Oral Contraceptive Monophasic combination
Product Image Turquoise dispenser with 3 Camrese® blister cards
Note
Camrese® (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note
Note: Camrese® is also listed under “Extended-cycle combination.”
Strength
0.15 mg/0.03 mg; 0.01 mg
Type of Oral Contraceptive Monophasic combination
Product Image Yellow dispenser with 3 Camrese Lo® blister cards
Note
Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note: Camrese®Lo is also listed under “Extended-cycle combination.”
Note
Note: Camrese®Lo is also listed under “Extended-cycle combination.”
Brand
LoSeasonique®
Strength
0.1 mg/0.02 mg; 0.01 mg
Type of Oral Contraceptive Monophasic combination
Product Image Yellow dispenser with 3 Camrese Lo® blister cards
Note
Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note
Note: Camrese®Lo is also listed under “Extended-cycle combination.”
Strength
0.1 mg/0.02 mg; 0.01 mg
Type of Oral Contraceptive Monophasic combination
Product Image Cryselle® 28 blister card
Note
Cryselle® (norgestrel and ethinyl estradiol tablets, USP)
Note
Brand
Lo/Ovral®
Strength
0.3 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Cryselle® 28 blister card
Note
Cryselle® (norgestrel and ethinyl estradiol tablets, USP)
Strength
0.3 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Gianvi® blister card
Note
Gianvi® (drospirenone and ethinyl estradiol tablets)
Note
Brand
Yaz®
Strength
3 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Gianvi® blister card
Note
Gianvi® (drospirenone and ethinyl estradiol tablets)
Strength
3 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Pink dispenser with 3 Jolessa® blister cards
Note
Jolessa® (levonorgestrel/ethinyl estradiol tablets)
Note: Jolessa® is also listed under “Extended-cycle combination.”
Note
Note: Jolessa® is also listed under “Extended-cycle combination.”
Brand
Seasonale®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Pink dispenser with 3 Jolessa® blister cards
Note
Jolessa® (levonorgestrel/ethinyl estradiol tablets)
Note
Note: Jolessa® is also listed under “Extended-cycle combination.”
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® 1/20 blister card
Note
Junel® 1/20 (norethindrone acetate and ethinyl estradiol tablets, USP)
Note
Brand
Loestrin® 21
Strength
1 mg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® 1/20 blister card
Note
Junel® 1/20 (norethindrone acetate and ethinyl estradiol tablets, USP)
Strength
1 mg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® 1.5/30 blister card
Note
Junel® 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP)
Note
Brand
Loestrin® 21
Strength
1.5 mg/30 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® 1.5/30 blister card
Note
Junel® 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP)
Strength
1.5 mg/30 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® Fe 1/20 blister card
Note
Junel® Fe 1/20 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Note
Brand
Loestrin® Fe
Strength
1 mg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® Fe 1/20 blister card
Note
Junel® Fe 1/20 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Strength
1 mg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® Fe 1.5/30 blister card
Note
Junel® Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Note
Brand
Loestrin® Fe
Strength
1.5 mg/30 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® Fe 1.5/30 blister card
Note
Junel® Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Strength
1.5 mg/30 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® Fe 24 blister card
Note
Junel® Fe 24 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets*)
Note
Brand
Loestrin® 24 Fe
Strength
1 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Junel® Fe 24 blister card
Note
Junel® Fe 24 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets*)
Strength
1 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Kariva® blister card
Note
Kariva® (desogestrel/ethinyl estradiol and ethinyl estradiol tablets, USP)
Note
Brand
Mircette®
Strength
0.15 mg/0.02 mg; 0.01 mg
Type of Oral Contraceptive Monophasic combination
Product Image Kariva® blister card
Note
Kariva® (desogestrel/ethinyl estradiol and ethinyl estradiol tablets, USP)
Strength
0.15 mg/0.02 mg; 0.01 mg
Type of Oral Contraceptive Monophasic combination
Product Image Kelnor® 1/35 blister card
Note
Kelnor® 1/35 (ethynodiol diacetate and ethinyl estradiol tablets, USP)
Note
Brand
Demulen®
Strength
1 mg/35 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Kelnor® 1/35 blister card
Note
Kelnor® 1/35 (ethynodiol diacetate and ethinyl estradiol tablets, USP)
Strength
1 mg/35 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Layolis™ Fe blister card
Note
Layolis™ Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets*)
Note
Brand
Generess® Fe
Strength
0.8 mg/25 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Layolis™ Fe blister card
Note
Layolis™ Fe (norethindrone and ethinyl estradiol chewable tablets and ferrous fumarate chewable tablets*)
Strength
0.8 mg/25 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Lessina® blister card
Note
Lessina® (levonorgestrel and ethinyl estradiol tablets, USP)
Note
Brand
Levlite®
Strength
0.1 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Lessina® blister card
Note
Lessina® (levonorgestrel and ethinyl estradiol tablets, USP)
Strength
0.1 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image  Green dispenser with Microgestin® 24 Fe blister card
Note
Microgestin® 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Note
Brand
Loestrin® 24 Fe
Strength
1 mg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image  Green dispenser with Microgestin® 24 Fe blister card
Note
Microgestin® 24 Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Strength
1 mg/20 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Yellow compact with Mononessa® blister card
Note
MonoNessa® (norgestimate and ethinyl estradiol tablets)
Note
Brand
Ortho-Cyclen®
Strength
0.25 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Yellow compact with Mononessa® blister card
Note
MonoNessa® (norgestimate and ethinyl estradiol tablets)
Strength
0.25 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Necon® 1/50 blister card and pink dispenser
Note
Necon® 1/50 (norethindrone and mestranol tablets USP)
Note
Brand
Norinyl® 1/50
Strength
1 mg/0.05 mg
Type of Oral Contraceptive Monophasic combination
Product Image Necon® 1/50 blister card and pink dispenser
Note
Necon® 1/50 (norethindrone and mestranol tablets USP)
Strength
1 mg/0.05 mg
Type of Oral Contraceptive Monophasic combination
Product Image Nortrel® blister card
Note
Nortrel® 0.5/35 (norethindrone and ethinyl estradiol tablets, USP)
Note
Brand
ModiCon®
Strength
0.5 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Nortrel® blister card
Note
Nortrel® 0.5/35 (norethindrone and ethinyl estradiol tablets, USP)
Strength
0.5 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Nortrel® 1/35 (21-day regimen) blister card
Note
Nortrel® 1/35 (norethindrone and ethinyl estradiol tablets, USP)
(21 day regimen)
Note
Brand
Ortho-Novum® 1/35
Strength
1 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Nortrel® 1/35 (21-day regimen) blister card
Note
Nortrel® 1/35 (norethindrone and ethinyl estradiol tablets, USP)
(21 day regimen)
Strength
1 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Nortrel® 1/35 (28-day regimen) blister card
Note
Nortrel® 1/35 (norethindrone and ethinyl estradiol tablets, USP)
(28 day regimen)
Note
Brand
Ortho-Novum® 1/35
Strength
1 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Nortrel® 1/35 (28-day regimen) blister card
Note
Nortrel® 1/35 (norethindrone and ethinyl estradiol tablets, USP)
(28 day regimen)
Strength
1 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Ocella® blister card
Note
Ocella® (drospirenone and ethinyl estradiol tablets)
Note
Brand
Yasmin®
Strength
3 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Ocella® blister card
Note
Ocella® (drospirenone and ethinyl estradiol tablets)
Strength
3 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Grey dispenser with Ogestrel® 0.5/50 blister card
Note
Ogestrel® 0.5/50 (norgestrel and ethinyl estradiol tablets USP)
Note
Brand
Ovral®
Strength
0.5 mg/0.05 mg
Type of Oral Contraceptive Monophasic combination
Product Image Grey dispenser with Ogestrel® 0.5/50 blister card
Note
Ogestrel® 0.5/50 (norgestrel and ethinyl estradiol tablets USP)
Strength
0.5 mg/0.05 mg
Type of Oral Contraceptive Monophasic combination
Product Image Portia® blister card
Note
Portia® (levonorgestrel and ethinyl estradiol tablets, USP)
Note
Brand
Nordette®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Portia® blister card
Note
Portia® (levonorgestrel and ethinyl estradiol tablets, USP)
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image 3 Quasense® blister cards and peach dispenser
Note
Quasense® (levonorgestrel and ethinyl estradiol tablets USP)
Note: Quasense® is also listed under “Extended-cycle combination.”
Note
Note: Quasense® is also listed under “Extended-cycle combination.”
Brand
Seasonale®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image 3 Quasense® blister cards and peach dispenser
Note
Quasense® (levonorgestrel and ethinyl estradiol tablets USP)
Note
Note: Quasense® is also listed under “Extended-cycle combination.”
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Rajani™ blister card and grey dispenser
Note
Rajani™ (drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets)
Note
Brand
Beyaz®
Strength
3 mg/0.02 mg/ 0.451 mg; 0.451 mg
Type of Oral Contraceptive Monophasic combination
Product Image Rajani™ blister card and grey dispenser
Note
Rajani™ (drospirenone, ethinyl estradiol and levomefolate calcium tablets and levomefolate calcium tablets)
Strength
3 mg/0.02 mg/ 0.451 mg; 0.451 mg
Type of Oral Contraceptive Monophasic combination
Product Image Brown dispenser with Reclipsen™ blister card
Note
Reclipsen™ (desogestrel and ethinyl estradiol tablets USP)
Note
Brand
Ortho-Cept®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Brown dispenser with Reclipsen™ blister card
Note
Reclipsen™ (desogestrel and ethinyl estradiol tablets USP)
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Monophasic combination
Product Image Sprintec® blister card
Note
Sprintec® (norgestimate and ethinyl estradiol tablets, USP)
Note
Brand
Ortho-Cyclen®
Strength
0.25 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Sprintec® blister card
Note
Sprintec® (norgestimate and ethinyl estradiol tablets, USP)
Strength
0.25 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Vestura™ blister card and blue dispenser
Note
Vestura™ (drospirenone and ethinyl estradiol tablets)
Note
Brand
Yaz®
Strength
3 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Vestura™ blister card and blue dispenser
Note
Vestura™ (drospirenone and ethinyl estradiol tablets)
Strength
3 mg/0.02 mg
Type of Oral Contraceptive Monophasic combination
Product Image Zenchent® 0.4/35 blister card
Note
Zenchent® 0.4/35 (norethindrone and ethinyl estradiol tablets USP)
Note
Brand
Ovcon® 35
Strength
0.4 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Zenchent® 0.4/35 blister card
Note
Zenchent® 0.4/35 (norethindrone and ethinyl estradiol tablets USP)
Strength
0.4 mg/0.035 mg
Type of Oral Contraceptive Monophasic combination
Product Image Pink dispenser with Zovia® 1/50E-28 blister card
Note
Zovia® 1/50E (ethynodiol diacetate and ethinyl estradiol tablets USP)
Note
Brand
Demulen®
Strength
1 mg/50 mcg
Type of Oral Contraceptive Monophasic combination
Product Image Pink dispenser with Zovia® 1/50E-28 blister card
Note
Zovia® 1/50E (ethynodiol diacetate and ethinyl estradiol tablets USP)
Strength
1 mg/50 mcg
Type of Oral Contraceptive Multiphasic combination
Product Image Aranelle® blister card
Note
Aranelle® (norethindrone and ethinyl estradiol tablets, USP) - triphasic regimen
Note
Brand
Tri-Norinyl®
Strength
0.5 mg/0.035 mg; 1mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Aranelle® blister card
Note
Aranelle® (norethindrone and ethinyl estradiol tablets, USP) - triphasic regimen
Strength
0.5 mg/0.035 mg; 1mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Enpresse® blister card
Note
Enpresse® (levonorgestrel and ethinyl estradiol tablets, USP - triphasic regimen)
Note
Brand
Triphasil®
Strength
0.05 mg/0.03 mg; 0.075 mg/0.04 mg; 0.125 mg/0.03 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Enpresse® blister card
Note
Enpresse® (levonorgestrel and ethinyl estradiol tablets, USP - triphasic regimen)
Strength
0.05 mg/0.03 mg; 0.075 mg/0.04 mg; 0.125 mg/0.03 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Yellow compact with Necon 7/7/7® blister card
Note
Necon 7/7/7® (norethindrone and ethinyl estradiol tablets)
Note
Brand
Ortho-Novum® 7/7/7
Strength
0.5 mg/0.035 mg; 0.75 mg/0.035 mg; 1 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Yellow compact with Necon 7/7/7® blister card
Note
Necon 7/7/7® (norethindrone and ethinyl estradiol tablets)
Strength
0.5 mg/0.035 mg; 0.75 mg/0.035 mg; 1 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Nortrel® 7/7/7 blister card
Note
Nortrel® 7/7/7 (norethindrone and ethinyl estradiol tablets, USP - triphasic regimen)
Note
Brand
Ortho-Novum® 7/7/7
Strength
0.5 mg/0.035 mg; 0.75 mg/0.035 mg; 1 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Nortrel® 7/7/7 blister card
Note
Nortrel® 7/7/7 (norethindrone and ethinyl estradiol tablets, USP - triphasic regimen)
Strength
0.5 mg/0.035 mg; 0.75 mg/0.035 mg; 1 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Tri-Legest® Fe 28 blister card
Note
Tri-Legest® Fe 28 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Note
Brand
Estrostep® Fe
Strength
1 mg/20 mcg; 1 mg/30 mcg; 1 mg/35 mcg
Type of Oral Contraceptive Multiphasic combination
Product Image Tri-Legest® Fe 28 blister card
Note
Tri-Legest® Fe 28 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
Strength
1 mg/20 mcg; 1 mg/30 mcg; 1 mg/35 mcg
Type of Oral Contraceptive Multiphasic combination
Product Image Tri-Lo-Sprintec® blister card
Note
Tri-Lo-Sprintec® (norgestimate and ethinyl estradiol tablets, USP - triphasic regimen)
Note
Brand
Ortho Tri-Cyclen® Lo
Strength
0.18 mg/0.025 mg; 0.215 mg/0.025 mg; 0.25 mg/0.025 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Tri-Lo-Sprintec® blister card
Note
Tri-Lo-Sprintec® (norgestimate and ethinyl estradiol tablets, USP - triphasic regimen)
Strength
0.18 mg/0.025 mg; 0.215 mg/0.025 mg; 0.25 mg/0.025 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Yellow compact with TriNessa® blister card
Note
TriNessa® (norgestimate and ethinyl estradiol tablets)
Note
Brand
Ortho Tri-Cyclen®
Strength
0.18 mg/0.035 mg; 0.215 mg/0.035 mg; 0.25 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Yellow compact with TriNessa® blister card
Note
TriNessa® (norgestimate and ethinyl estradiol tablets)
Strength
0.18 mg/0.035 mg; 0.215 mg/0.035 mg; 0.25 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image
Note
TriNessa® Lo (norgestimate and ethinyl estradiol tablets)
Note
Brand
Ortho Tri-Cyclen® Lo
Strength
0.18 mg/0.025 mg; 0.215 mg/0.025 mg; 0.25 mg/0.025 mg
Type of Oral Contraceptive Multiphasic combination
Product Image
Note
TriNessa® Lo (norgestimate and ethinyl estradiol tablets)
Strength
0.18 mg/0.025 mg; 0.215 mg/0.025 mg; 0.25 mg/0.025 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Tri-Sprintec® blister card
Note
Tri-Sprintec® (norgestimate and ethinyl estradiol tablets, USP)
Note
Brand
Ortho Tri-Cyclen®
Strength
0.18 mg/0.035 mg; 0.215 mg/0.035 mg; 0.25 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Tri-Sprintec® blister card
Note
Tri-Sprintec® (norgestimate and ethinyl estradiol tablets, USP)
Strength
0.18 mg/0.035 mg; 0.215 mg/0.035 mg; 0.25 mg/0.035 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Velivet® blister card
Note
Velivet® (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen)
Note
Brand
Cyclessa®
Strength
0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg
Type of Oral Contraceptive Multiphasic combination
Product Image Velivet® blister card
Note
Velivet® (desogestrel and ethinyl estradiol tablets, USP - triphasic regimen)
Strength
0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image Turquoise dispenser with 3 Camrese® blister cards
Note
Camrese® (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note: Camrese® is also listed under “Monophasic combination.”
Note
Note: Camrese® is also listed under “Monophasic combination.”
Brand
Seasonique®
Strength
0.15 mg/0.03 mg; 0.01 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image Turquoise dispenser with 3 Camrese® blister cards
Note
Camrese® (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note
Note: Camrese® is also listed under “Monophasic combination.”
Strength
0.15 mg/0.03 mg; 0.01 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image Yellow dispenser with 3 Camrese Lo® blister cards
Note
Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note: Camrese®Lo is also listed under “Monophasic combination.”
Note
Note: Camrese®Lo is also listed under “Monophasic combination.”
Brand
LoSeasonique®
Strength
0.1 mg/0.02 mg; 0.01 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image Yellow dispenser with 3 Camrese Lo® blister cards
Note
Camrese®Lo (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets)
Note
Note: Camrese®Lo is also listed under “Monophasic combination.”
Strength
0.1 mg/0.02 mg; 0.01 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image Pink dispenser with 3 Jolessa® blister cards
Note
Jolessa® (levonorgestrel/ethinyl estradiol tablets)
Note: Jolessa® is also listed under “Monophasic combination.”
Note
Note: Jolessa® is also listed under “Monophasic combination.”
Brand
Seasonale®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image Pink dispenser with 3 Jolessa® blister cards
Note
Jolessa® (levonorgestrel/ethinyl estradiol tablets)
Note
Note: Jolessa® is also listed under “Monophasic combination.”
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image 3 Quasense® blister cards and peach dispenser
Note
Quasense® (levonorgestrel and ethinyl estradiol tablets USP)
Note: Quasense® is also listed under “Monophasic combination.”
Note
Note: Quasense® is also listed under “Monophasic combination.”
Brand
Seasonale®
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Extended-cycle combination
Product Image 3 Quasense® blister cards and peach dispenser
Note
Quasense® (levonorgestrel and ethinyl estradiol tablets USP)
Note
Note: Quasense® is also listed under “Monophasic combination.”
Strength
0.15 mg/0.03 mg
Type of Oral Contraceptive Continuous-cycle combination
Product Image Amethyst® blister card and purple dispenser
Note
Amethyst® (levonorgestrel and ethinyl estradiol tablets, USP)
Note: Amethyst® is also listed under “Monophasic combination.”
Note
Note: Amethyst® is also listed under “Monophasic combination.”
Brand
Lybrel®
Strength
90 mcg/20 mcg
Type of Oral Contraceptive Continuous-cycle combination
Product Image Amethyst® blister card and purple dispenser
Note
Amethyst® (levonorgestrel and ethinyl estradiol tablets, USP)
Note
Note: Amethyst® is also listed under “Monophasic combination.”
Strength
90 mcg/20 mcg
* Ferrous fumarate tablets are not USP for dissolution and assay. Strength of ferrous fumarate not denoted in chart.
The brands listed are trademarks of their respective owners, some of which may no longer be marketed. Additional information and resources for these products are available at TevaGenerics.com.

Oral contraceptives are indicated for use by women to prevent pregnancy. Oral contraceptives do not protect against HIV infection (AIDS) and other sexually transmitted diseases.

IMPORTANT SAFETY INFORMATION

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular events from oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, oral contraceptives should not be used by women who are over 35 years of age and smoke.

Do not prescribe oral contraceptives to women who are known to have the following conditions:

  • A high risk of arterial or venous thrombotic diseases. Examples include women who are known to smoke, if over age 35, or women who have: deep vein thrombosis or pulmonary embolism, now or in the past; cerebrovascular disease; coronary artery disease; thrombogenic valvular or thrombogenic rhythm diseases of the heart; inherited or acquired hypercoagulopathies; uncontrolled hypertension; diabetes with vascular disease; or headaches with focal neurological symptoms or have migraine headaches with or without aura if over age 35.
  • Liver tumors, benign or malignant, or liver disease.
  • Renal impairment or adrenal insufficiency.
  • Undiagnosed abnormal uterine bleeding.
  • Pregnancy, because there is no reason to use oral contraceptives during pregnancy.
  • Breast cancer or other estrogen- or progestin-sensitive cancer, now or in the past.
  • Hypersensitivity to any component of the oral contraceptive product.

Serious adverse reactions associated with the use of oral contraceptives include thrombophlebitis; arterial thromboembolism; pulmonary embolism; myocardial infarction; cerebral hemorrhage; cerebral thrombosis; hypertension; gallbladder disease; hepatic adenomas or benign liver tumors; hyperkalemia; carbohydrate and lipid metabolic effects; ectopic pregnancy; delayed follicular atresia/ovarian cysts; carcinoma of the breast and reproductive organs; genital bleeding irregularities; and onset of or change in migraine/headache.

Common adverse reactions reported for oral contraceptives include menstrual irregularities or disorders; irregular uterine bleeding; nausea; vomiting; breast pain, tenderness or discomfort; headache; migraine; vaginal infection; genital discharge; weight changes (increased or decreased); abdominal pain, tenderness or discomfort; anxiety symptoms; depression or mood changes or disorders; acne; fatigue; irritability; decreased libido; affect lability; flatulence, nervousness, and rash.

Before prescribing any oral contraceptive on this chart, please read the accompanying full Prescribing Information for the specific product.

Oral contraceptives are indicated for use by women to prevent pregnancy. Oral contraceptives do not protect against HIV infection (AIDS) and other sexually transmitted diseases.

IMPORTANT SAFETY INFORMATION

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS

Cigarette smoking increases the risk of serious cardiovascular events from oral contraceptive use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, oral contraceptives should not be used by women who are over 35 years of age and smoke.

Do not prescribe oral contraceptives to women who are known to have the following conditions:

  • A high risk of arterial or venous thrombotic diseases. Examples include women who are known to smoke, if over age 35, or women who have: deep vein thrombosis or pulmonary embolism, now or in the past; cerebrovascular disease; coronary artery disease; thrombogenic valvular or thrombogenic rhythm diseases of the heart; inherited or acquired hypercoagulopathies; uncontrolled hypertension; diabetes with vascular disease; or headaches with focal neurological symptoms or have migraine headaches with or without aura if over age 35.
  • Liver tumors, benign or malignant, or liver disease.
  • Renal impairment or adrenal insufficiency.
  • Undiagnosed abnormal uterine bleeding.
  • Pregnancy, because there is no reason to use oral contraceptives during pregnancy.
  • Breast cancer or other estrogen- or progestin-sensitive cancer, now or in the past.
  • Hypersensitivity to any component of the oral contraceptive product.

Serious adverse reactions associated with the use of oral contraceptives include thrombophlebitis; arterial thromboembolism; pulmonary embolism; myocardial infarction; cerebral hemorrhage; cerebral thrombosis; hypertension; gallbladder disease; hepatic adenomas or benign liver tumors; hyperkalemia; carbohydrate and lipid metabolic effects; ectopic pregnancy; delayed follicular atresia/ovarian cysts; carcinoma of the breast and reproductive organs; genital bleeding irregularities; and onset of or change in migraine/headache.

Common adverse reactions reported for oral contraceptives include menstrual irregularities or disorders; irregular uterine bleeding; nausea; vomiting; breast pain, tenderness or discomfort; headache; migraine; vaginal infection; genital discharge; weight changes (increased or decreased); abdominal pain, tenderness or discomfort; anxiety symptoms; depression or mood changes or disorders; acne; fatigue; irritability; decreased libido; affect lability; flatulence, nervousness, and rash.

Before prescribing any oral contraceptive on this chart, please read the accompanying full Prescribing Information for the specific product.